Navigation Links
Advent of New, More Effective and Personalized Medicines

The FDA today issued a final guidance titled "Pharmacogenomic Data Submissions" to speed// development of new medical products through the science of pharmacogenomics.

Pharmacogenomics allows health care providers to identify sources of an individual's profile of drug response and predict the best possible treatment option for this individual. This technology has enabled the development of targeted therapies like Herceptin for metastatic breast cancer, Gleevec for chronic myeloid leukemia and Erbitux for metastatic colorectal cancer.

This new approach will allow medicines to be uniquely crafted to maximize their therapeutic benefits and minimize the potential risks for each patient. Doctors will eventually be able to analyze a patient's genetic profile and prescribe the best available drug therapy and dose from the start.

FDA also approved the first laboratory test, the Amplichip Cytochrome P450 Genotyping Test, which will enable physicians to use genetic information to select the right doses of certain medications for cardiac, psychiatric diseases and cancer.

The final guidance describes what data will be needed during the marketing application review process, the format for submissions, and the data that will be used during regulatory decision-making. The guidance also explains a new mechanism for industry to voluntarily submit research data to further the scientific exchange of information as we move into more advanced areas of pharmacogenomic research.

The voluntary data, will be reviewed by an internal, agency-wide group and will not be used for regulatory decision making, but will help FDA and industry gain valuable experience. FDA believes this approach will save time and resources and eliminate possible delays in the application review process.

FDA has already received several pharmacogenomic data submissions through both the regulatory and voluntary processes and will continue to work cl osely with industry and the healthcare community.

In addition to announcing the availability of its final guidance and the new pharmacogenomic Web page, the agency also reminded the public of the meeting being held on pharmacogenomics issues.

The joint FDA/DIA meeting, "Pharmacogenomics in Drug Development and Regulatory Decision Making” will focus on integrating pharmacogenomics in clinical trials for new drugs, biologics, and associated devices. FDA will also address ways to translate pharmacogenomics into medical product development and clinical practice.


'"/>




Related medicine news :

1. Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way
2. Adrenaline Associated With Adventurers Risk Taking
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. Inhaled Steroids Safe & Effective for Children with Asthma
5. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
6. Fluoride Found Effective in Osteoporosis
7. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
8. Implantable Contact Lens Found Safe and Effective
9. Effective And Economical Agent For Anthrax
10. Stem Cell Transplants May Be Effective For MS Patients
11. Effective therapy for Huntingtons disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2018)... , ... December 06, 2018 , ... ... the tropical disease schistosomiasis significantly faster than the drug most commonly used against ... the Democratic Republic of Congo. The study’s authors, including a professor and two ...
(Date:12/5/2018)... ... 2018 , ... Adam Devlin , co-founder and owner ... on Philadelphia Mayor James F. Kenney’s Commission on People with Disabilities. The commission ... cognitive or physical disability. Devlin serves as the chair of the Behavioral Health ...
(Date:12/5/2018)... LOUIS PARK, Minn. (PRWEB) , ... December 05, 2018 , ... ... its original, engaging, personalized fitness content to the masses. Wellbeats , which has ... clients, has released a new Wellbeats consumer app. Available now in the Apple ...
(Date:12/5/2018)... ... December 05, 2018 , ... Since PermaLip™ implants are solid, patients ... to the naked eye, ensuring a natural look. “I always double and triple check ... signs of implant visibility,” says Dr. Jessica Kulak, double board certified facial plastic surgeon ...
(Date:12/5/2018)... ... December 05, 2018 , ... Domenic Palmieri has been named ... will be responsible for the executive oversight of operations for three core divisions ... search for this position,” Tom Doran, president, HM Insurance Group, said. “And while ...
Breaking Medicine News(10 mins):
(Date:12/8/2018)... ... 07, 2018 , ... OnlineMasters.com, an industry-leading educational research organization, ... for 2019. They have identified the top programs in the nation that are ... outcomes. , Leveraging an exclusive data set comprised of interviews and surveys from ...
(Date:12/6/2018)... ... ... Last year, 172 children deaths were reported for the 2017-18 flu season—a record ... Vaccination is the first step in protecting against the flu for people 6 months ... infected. Along with getting vaccinated, people can take active steps to limit the spread ...
(Date:12/6/2018)... ... December 06, 2018 , ... Every day, and especially during the holidays, ... best way to clean up (and throw away) bacteria-filled messes, and to prevent germs ... which can spread germs around other kitchen surfaces and increase the odds of cross-contamination. ...
Breaking Medicine Technology: